Using ctDNA to predict recurrence and response in colorectal cancer
Using ctDNA to predict recurrence and response in colorectal cancer
Chemoradiotherapy plus induction or consolidation chemotherapy as total neoadjuvant therapy for locally advanced rectal cancer
Treating HER2-mutant advanced biliary tract cancer with neratinib
CAPTEM vs FOLFIRI as second-line treatment for mCRC patients
VOLTAGE: Use of nivolumab monotherapy and radical surgery in patients with locally advanced rectal cancer
TRIBE2: Latest data for patients with mCRC
Entrectinib in NTRK-fusion positive gastrointestinal cancers
Latest results from KEYNOTE-181: Pembrolizumab versus chemotherapy as a second-line therapy for advanced oesophageal cancer
Challenges in global cancer control
Implementing the Breast Health Global Initiative guidelines
Cancer care in Latin America
ASCO 2019 and vision for cancer control